Terms: = Prostate cancer AND CDKN2A, CDK4I, 1029, ENSG00000147889, P42771, p14, CMM2, ARF, TP16, p16, MTS1, p19, p16INK4a, INK4a, CDKN2, p16INK4, p14ARF, MLM, INK4 AND Prognosis
35 results:
1. Genomic characterization of IDH-mutant astrocytoma progression to grade 4 in the treatment setting.
Rautajoki KJ; Jaatinen S; Hartewig A; Tiihonen AM; Annala M; Salonen I; Valkonen M; Simola V; Vuorinen EM; Kivinen A; Rauhala MJ; Nurminen R; Maass KK; Lahtela SL; Jukkola A; Yli-Harja O; Helén P; Pajtler KW; Ruusuvuori P; Haapasalo J; Zhang W; Haapasalo H; Nykter M
Acta Neuropathol Commun; 2023 Nov; 11(1):176. PubMed ID: 37932833
[TBL] [Abstract] [Full Text] [Related]
2. Senescent Tumor Cells Are Frequently Present at the Invasion Front: Implications for Improving Disease Control in Patients with Locally Advanced prostate cancer.
Schwarz S; Nientiedt C; Prigge ES; Kaczorowski A; Geisler C; Lucena Porcel C; von Knebel Doeberitz M; Hohenfellner M; Duensing S
Pathobiology; 2023; 90(5):312-321. PubMed ID: 37004506
[TBL] [Abstract] [Full Text] [Related]
3. Multi-candidate immunohistochemical markers to assess radiation response and prognosis in prostate cancer: results from the CHHiP trial of radiotherapy fractionation.
Wilkins A; Gusterson B; Tovey H; Griffin C; Stuttle C; Daley F; Corbishley CM; Dearnaley D; Hall E; Somaiah N
EBioMedicine; 2023 Feb; 88():104436. PubMed ID: 36708693
[TBL] [Abstract] [Full Text] [Related]
4. UBE2S as a novel ubiquitinated regulator of p16 and β-catenin to promote bone metastasis of prostate cancer.
Peng S; Chen X; Huang C; Yang C; Situ M; Zhou Q; Ling Y; Huang H; Huang M; Zhang Y; Cheng L; Zhang Q; Guo Z; Lai Y; Huang J
Int J Biol Sci; 2022; 18(8):3528-3543. PubMed ID: 35637955
[TBL] [Abstract] [Full Text] [Related]
5. KMT2C methyltransferase domain regulated ink4a expression suppresses prostate cancer metastasis.
Limberger T; Schlederer M; Trachtová K; Garces de Los Fayos Alonso I; Yang J; Högler S; Sternberg C; Bystry V; Oppelt J; Tichý B; Schmeidl M; Kodajova P; Jäger A; Neubauer HA; Oberhuber M; Schmalzbauer BS; Pospisilova S; Dolznig H; Wadsak W; Culig Z; Turner SD; Egger G; Lagger S; Kenner L
Mol Cancer; 2022 Mar; 21(1):89. PubMed ID: 35354467
[TBL] [Abstract] [Full Text] [Related]
6. Dihydroartemisinin induces cell apoptosis through repression of UHRF1 in prostate cancer cells.
Xia T; Liu S; Xu G; Zhou S; Luo Z
Anticancer Drugs; 2022 Jan; 33(1):e113-e124. PubMed ID: 34387595
[TBL] [Abstract] [Full Text] [Related]
7. Differences in Genomic Alterations Between Brain Metastases and Primary Tumors.
Dono A; Takayasu T; Yan Y; Bundrant BE; Arevalo O; Lopez-Garcia CA; Esquenazi Y; Ballester LY
Neurosurgery; 2021 Feb; 88(3):592-602. PubMed ID: 33369669
[TBL] [Abstract] [Full Text] [Related]
8. Single-Center Analysis of Human Papillomavirus Infection and p16ink4a Expression among Korean Patients with Penile cancer.
Kwon WA; Yoon MY; Kim SH; Seo HK; Chung J; Lee KH; Joung JY; Park WS
Biomed Res Int; 2019; 2019():6940582. PubMed ID: 31032357
[TBL] [Abstract] [Full Text] [Related]
9. Meta-analysis of cdkn2a methylation to find its role in prostate cancer development and progression, and also to find the effect of cdkn2a expression on disease-free survival (PRISMA).
Cao Z; Wei L; Zhu W; Yao X
Medicine (Baltimore); 2018 Mar; 97(12):e0182. PubMed ID: 29561434
[TBL] [Abstract] [Full Text] [Related]
10. p16 upregulation is linked to poor prognosis in ERG negative prostate cancer.
Burdelski C; Dieckmann T; Heumann A; Hube-Magg C; Kluth M; Beyer B; Steuber T; Pompe R; Graefen M; Simon R; Minner S; Tsourlakis MC; Koop C; Izbicki J; Sauter G; Krech T; Schlomm T; Wilczak W; Lebok P
Tumour Biol; 2016 Sep; 37(9):12655-12663. PubMed ID: 27444279
[TBL] [Abstract] [Full Text] [Related]
11. Mechanism of paclitaxel resistance in a human prostate cancer cell line, PC3-PR, and its sensitization by cabazitaxel.
Sobue S; Mizutani N; Aoyama Y; Kawamoto Y; Suzuki M; Nozawa Y; Ichihara M; Murate T
Biochem Biophys Res Commun; 2016 Oct; 479(4):808-813. PubMed ID: 27687545
[TBL] [Abstract] [Full Text] [Related]
12. Prognostic Factors of prostate cancer in Tunisian Men: Immunohistochemical Study.
Missaoui N; Abdelkarim SB; Mokni M; Hmissa S
Asian Pac J Cancer Prev; 2016; 17(5):2655. PubMed ID: 27268646
[TBL] [Abstract] [Full Text] [Related]
13. prostate tumor overexpressed-1, in conjunction with human papillomavirus status, predicts outcome in early-stage human laryngeal squamous cell carcinoma.
Yang L; Wang H; Wang Y; He Z; Chen H; Liang S; He S; Wu S; Song L; Chen Y
Oncotarget; 2016 May; 7(22):31878-91. PubMed ID: 26992242
[TBL] [Abstract] [Full Text] [Related]
14. miR-24 regulates CDKN1B/p27 expression in prostate cancer.
Lynch SM; McKenna MM; Walsh CP; McKenna DJ
Prostate; 2016 May; 76(7):637-48. PubMed ID: 26847530
[TBL] [Abstract] [Full Text] [Related]
15. Cyclin D1 Loss Distinguishes Prostatic Small-Cell Carcinoma from Most Prostatic Adenocarcinomas.
Tsai H; Morais CL; Alshalalfa M; Tan HL; Haddad Z; Hicks J; Gupta N; Epstein JI; Netto GJ; Isaacs WB; Luo J; Mehra R; Vessella RL; Karnes RJ; Schaeffer EM; Davicioni E; De Marzo AM; Lotan TL
Clin Cancer Res; 2015 Dec; 21(24):5619-29. PubMed ID: 26246306
[TBL] [Abstract] [Full Text] [Related]
16. Chromosome 9p deletion in clear cell renal cell carcinoma predicts recurrence and survival following surgery.
El-Mokadem I; Fitzpatrick J; Bondad J; Rauchhaus P; Cunningham J; Pratt N; Fleming S; Nabi G
Br J Cancer; 2014 Sep; 111(7):1381-90. PubMed ID: 25137021
[TBL] [Abstract] [Full Text] [Related]
17. [Comparative analysis of gene expression in normal and cancer human prostate cell lines].
Rosenberg IeE; Herashchenko HV; Kashuba VI
Ukr Biochem J; 2014; 86(2):119-28. PubMed ID: 24868918
[TBL] [Abstract] [Full Text] [Related]
18. Fibroblast growth factor receptor-1 as a potential therapeutic target in sinonasal cancer.
Schröck A; Göke F; Wagner P; Bode M; Franzen A; Huss S; Agaimy A; Ihrler S; Kirsten R; Kristiansen G; Bootz F; Lengerke C; Perner S
Head Neck; 2014 Sep; 36(9):1253-7. PubMed ID: 23913758
[TBL] [Abstract] [Full Text] [Related]
19. New developments in endocervical glandular lesions.
McCluggage WG
Histopathology; 2013 Jan; 62(1):138-60. PubMed ID: 23134447
[TBL] [Abstract] [Full Text] [Related]
20. DNA methylation changes correlate with Gleason score and tumor stage in prostate cancer.
Delgado-Cruzata L; Hruby GW; Gonzalez K; McKiernan J; Benson MC; Santella RM; Shen J
DNA Cell Biol; 2012 Feb; 31(2):187-92. PubMed ID: 21830905
[TBL] [Abstract] [Full Text] [Related]
[Next]